Sangre AgroTech’s Mission

To create a genomics-based Cannabis breeding program that will produce new, genetically-enhanced strains of Cannabis which express the desired plant characteristics for the treatment of disease and drug discovery.

Cannabis. Redefined.

what we do

At Sangre AgroTech, we all come to work every day because we are focused on the development and application of cannabis-derived compounds for the treatment of human disease.  Targeting cannabis-derived molecules which stimulate the endocannabinoid system, we are developing the required scientifically-valid and evidence-based cannabis strains for the production of disease-specific medicines.  Yes, medicines.

Sangre AgroTech is comprised of top-echelon scientists with extensive expertise in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry, utilizing the most advanced sequencing and analytical technologies and proprietary bioinformatics data systems available.

To quote our President and Chief Science Officer, Dr. Patrick Williams, “A comprehensive understanding of the annotated genome of a variety of cannabis strains will provide the blueprints for the development of significant medicinal products for the treatment of human diseases such as pediatric brain cancer, PTSD, epilepsy, chronic pain, and Crohn’s disease.”  We are dedicated to finding treatments and medical cures utilizing the Cannabaceae plant family.

Sangre AgroTech

team

news

WEED, Inc. Increases Investment Over $1,000,000 in Colorado Medicinal Cannabis Industry Sangre AgroTech to Open Bioscience Center in La Veta, Colorado TUCSON, AZ / ACCESSWIRE / July 18, 2017 /WEED, Inc. (OTC-PINK:BUDZ) (the “Company” or “WEED”), a current non-SEC reporting company, announced that its recent acquisition, Sangre AT, LLC (dba “Sangre AgroTech”), plans to open […]

Read more

Sangre AgroTech Cannabis Genomic Study Underway WEED, Inc.’s New Acquisition, Sangre AgroTech, Conducts Ground-Breaking Cannabis Research TUCSON, AZ / ACCESSWIRE / June 15, 2017 / WEED, Inc. (OTC PINK: BUDZ) (the “Company,” or ” WEED“), fka United Mines, Inc., a current alternative reporting public company, announced that its recent acquisition, Sangre AT, LLC (dba “Sangre AgroTech”), is […]

Read more

WEED, Inc. Announces Acquisition of Plant Genomic Research and Breeding Company, Sangre AT, LLC (dba, Sangre AgroTech) Sangre AgroTech’s team of experts launches Cannabis Genomic Study TUCSON, Ariz. — WEED, Inc. (BUDZ: OTC Pink) (the “Company” or “WEED”), fka United Mines, Inc., a current non-SEC reporting company, announced today the acquisition of Sangre AT, LLC […]

Read more

blog

Featured Posts

contact

Sangre AgroTech
P.O. Box 1118
La Veta, CO 81055

phone:  719.742.3652

mobile:  719.989.8743

If you have any questions or want to contact us, please leave us a message:

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.